Friday Frontline: April 5, 2019

Article

From today’s top entertainers and athletes to a ban on implants linked to cancer, here’s what is making headlines in the cancer space this week.

“Inside Edition” host Deborah Norville underwent surgery this week to remove a cancerous thyroid nodule that was spotted by a viewer years ago.

An initial check found the lump to be benign. But recently, her physician determined the nodule has become a very localized form of cancer that required surgery. “For years, it was nothing,” Norville said in a message to fans. “Until recently, it was something.” She will not need chemotherapy or radiation treatment.

Norville said of the lifesaving observation made by the viewer, “When you work on television, viewers comment on everything — your hair, your makeup, the dress you’re wearing. And, a long time ago, an ‘Inside Edition’ viewer reached out to say she’d seen something on my neck. It was a lump.”

Image courtesy of Deborah Norville's YouTube video announcement.

A North Carolina man with stage 4 liver cancer will take a dream vacation after winning the lottery. Retired mechanic Richard Beare of Charlotte, North Carolina, stopped for a Powerball ticket at his wife’s request. He also picked up four Carolina Black scratch-off tickets. The fourth one proving to be his lucky charm — he won $250,000. After taxes, Beare walked away with $176,876, according to the North Carolina Education Lottery website.

“I want to travel while I can still enjoy myself,” said Beare, who recently received the cancer diagnosis. “My wife has always wanted to go to Italy, since that’s where her descendants are from. Now I can take her.”

Richard Beare accepting his winnings. Image courtesy of North Carolina Education Lottery.

Pittsburgh Penguins defenseman Kris Letang donated $58,000 to help a 7-year-old fan pay for leukemia treatment. On Monday, the Pittsburgh Penguins tweeted a photo of Letang personally handing the check to Ian Rosenbaum after the Penguins’ practice last week. Incidentally, the five-time NHL all-star wears the number 58.

This was not the first time Letang and Rosenbaum met. They became fast friends after Rosenbaum requested to meet Letang following his T-cell leukemia diagnosis. Letang also attended a fundraiser held for Rosenbaum last November.

“For kids to go through this, it's just harsh,” Letang told the Tribune-Democrat. “Any way I could help, I felt I would do it.”

Image courtesy of Pittsburgh Penguins' Twitter.

An historic decision made by France to ban a popular breast implant type because of its link to a rare form of cancer. Le Monde newspaper and French public radio reported on Wednesday that textured implants and polyurethane breast implants have been associated with anaplastic large-cell lymphoma (BIA-ALCL), a “rare but serious danger.” Citing a letter from health authorities to implant manufacturers, Le Monde said France's National Agency for Medicines and Health Products had informed manufacturers on April 2 of its plans to ban “the manufacture, distribution, importing, exporting, promotion and wearing of textured breast implants and polyurethane breast implants.” The ban would affect approximately 85% of implant surgeries in the country. Over 400,000 individuals in France have the textured implants linked to BIA-ALCL.

Actress Jane Fonda, 81, opened up about her battles with recurring bouts of cancer. While the actress has previously kept quiet about her private life and health struggles, she opened up in an upcoming issue of British Vogue.

“I've had a lot of cancer,” she told the magazine. “I was a sun-worshipper. When I have a day off, I frequently go to my skin doctor and have things cut off me by a surgeon.”

Fonda also recalled how, at the 2016 Golden Globes during her nomination for Best Supporting Actress, she had just undergone a mastectomy. That didn’t prevent her from attending: “I get out of the car and I have the strange white dress with all the ruffles? That's because I'd just had a mastectomy and I had to cover my bandages,” she shared.

However, Fonda remained tight-lipped when asked to discuss her current diagnosis. “It's an ongoing process. So there's that,” Fonda said.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content